Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects

被引：4

作者：

Ravel-Chapuis, Aymeric ^{[1
,2
]}

Jasmin, Bernard J. ^{[1
,2
]}

机构：

[1] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada

[2] Univ Ottawa, Fac Med, Er Poulin Ctr Neuromuscular Dis, Ottawa, ON, Canada

来源：

TRENDS IN MOLECULAR MEDICINE | 2022年 / 28卷 / 06期

关键词：

D O I：

10.1016/j.molmed.2022.04.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder for which there is no cure. In recent years, progress has been made in defining disease mechanisms and in developing novel therapies, especially for skeletal muscle defects. Here, we highlight the potential of activating AMP-activated protein kinase (AMPK) with different approaches in combinatorial therapies.

引用

页码：439 / 442

页数：4

共 50 条

[41] Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy
Damiani, E
Angelini, C
Pelosi, M
Sacchetto, R
Bortoloso, E
Margreth, A
NEUROMUSCULAR DISORDERS, 1996, 6 (01) : 33 - 47
[42] SKELETAL-MUSCLE BIOENERGETICS IN MYOTONIC-DYSTROPHY
TAYLOR, DJ
KEMP, GJ
WOODS, CG
EDWARDS, JH
RADDA, GK
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 116 (02) : 193 - 200
[43] Transcriptome alterations in myotonic dystrophy skeletal muscle and heart
Wang, Eric T.
Treacy, Daniel
Eichinger, Katy
Struck, Adam
Estabrook, Joseph
Olafson, Hailey
Wang, Thomas T.
Bhatt, Kirti
Westbrook, Tony
Sedehizadeh, Sam
Ward, Amanda
Day, John
Brook, David
Berglund, J. Andrew
Cooper, Thomas
Housman, David
Thornton, Charles
Burge, Christopher
HUMAN MOLECULAR GENETICS, 2019, 28 (08) : 1312 - 1321
[44] Myotonic dystrophy type 1
Nguyen, Cam-Tu Emilie
Campbell, Craig
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (14) : 1033 - 1033
[45] Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy
Ueda, H
Shimokawa, M
Yamamoto, M
Kameda, N
Mizusawa, H
Baba, T
Terada, N
Fujii, Y
Ohno, S
Ishiura, S
Kobayashi, T
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 162 (01) : 38 - 50
[46] Skeletal muscle after a single bout of eccentric exercise in myotonic dystrophy type 1: a complete proteomic analysis
Roussel, M.
Hebert, L.
Gagnon, C.
Duchesne, E.
NEUROMUSCULAR DISORDERS, 2022, 32 : S133 - S133
[47] Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
De Serres-Berard, Thiery
Ait Benichou, Siham
Jauvin, Dominic
Boutjdir, Mohamed
Puymirat, Jack
Chahine, Mohamed
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[48] Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1
Ausems, Cornelia Rosanne Maria
Raaijmakers, Renee Henrica Lamberta
van den Broek, Walterus Johannes Antonius Adriana
Willemse, Marieke
van Engelen, Baziel Gerardus Maria
Wansink, Derick Gert
van Bokhoven, Hans
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 15 : 120 - 132
[49] Small nucleolar RNAs promote the restoration of muscle differentiation defects in cells from myotonic dystrophy type 1
Bogard, Baptiste
Bonnet, Helene
Boyarchuk, Ekaterina
Tellier, Gilles
Furling, Denis
Mouly, Vincent
Francastel, Claire
Hube, Florent
NUCLEIC ACIDS RESEARCH, 2025, 53 (06)
[50] Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies
Bachinski, Linda L.
Baggerly, Keith A.
Neubauer, Valerie L.
Nixon, Tamara J.
Raheem, Olayinka
Sirito, Mario
Unruh, Anna K.
Zhang, Jiexin
Nagarajan, Lalitha
Timchenko, Lubov T.
Bassez, Guillaume
Eymard, Bruno
Gamez, Josep
Ashizawa, Tetsuo
Mendell, Jerry R.
Udd, Bjame
Krahe, Ralf
NEUROMUSCULAR DISORDERS, 2014, 24 (03) : 227 - 240

← 1 2 3 4 5 →